Mira Pharmaceuticals Inc
MIRA
Get informed when a big investor buys or sells
+ FollowMarket Cap$34.97M
Close$
$0.27
68.1% downside
Current Fair Value
68.1% downsideOvervalued by 68.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $34.97 Million |
|---|---|
| Enterprise Value | $31.37 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.35 |
| Beta | 1.54 |
| Outstanding Shares | 42,022,087 |
Return
| Return on Equity | -380.24% |
|---|---|
| Return on Assets | -378.35% |
| Return on Invested Capital | 41.48% |
Valuation & Multiples
| P/E Ratio | -0.6 |
|---|---|
| PEG | 2.82 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 9.26 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
$-0.03
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 5.51%▲ 0.39% |
|---|---|
| Total Invested | $2.19M▼ 4.64% |
| Investors Holding | 260% |
ESG Score
No data